The Promise Of 4R Tau-Pet Tracer Development

The promise of 4R tau-PET tracer development

Promise of tau-PET imaging for Alzheimer's disease

Multi-PET tracers reveal the complex nature of 4R tauopathies

Time gap between amyloid- and tau-PET positivity in preclinical disease

Discriminative power of a multi-PET tracer approach in primary tauopathies

Functional imaging and tau PET tracers for diagnosing PSP & CBD

Why does tau-PET not detect the earliest stages of Alzheimer’s disease?

Longitudinal clinical outcomes of tau-PET-positive individuals

Optimization of Tau PET Imaging for Alzheimer’s Clinical Development

Advantages of tau-PET compared to amyloid-PET

Improving tau-PET harmonization: the HEAD study

Optimization of Tau PET Imaging for Alzheimer’s Clinical Development

The importance of new methods for monitoring tau pathology

Discriminatory ability of next-generation tau PET tracers for Alzheimer’s disease

Why Alzheimer’s disease research is focusing on tau

Limitations of [18F]flortaucipir tau-PET imaging

Tau PET in the diagnosis of Alzheimer's disease/Hiroshi Matsuda's Neuroimaging Complete Case#8

U

Tau ligands and the future of Tau PET imaging

Predicting amyloid PET and tau PET stages with plasma biomarkers

Current and future role of tau-PET in dementia daily practice